Long-term management of the liver transplant patient: recommendations for the primary care doctor.
No official document has been published for primary care physicians regarding the management of liver transplant patients. With no official source of reference, primary care physicians often question their care of these patients. The following guidelines have been approved by the American Society of Transplantation and represent the position of the association. The data presented are based on formal review and analysis of published literature in the field and the clinical experience of the authors. These guidelines address drug interactions and side effects of immunosuppressive agents, allograft dysfunction, renal dysfunction, metabolic disorders, preventive medicine, malignancies, disability and productivity in the workforce, issues specific to pregnancy and sexual function, and pediatric patient concerns. These guidelines are intended to provide a bridge between transplant centers and primary care physicians in the long-term management of the liver transplant patient.
McGuire
B M
BM
University of Alabama at Birmingham, Birmingham, AL, USA. bmcguire@uab.edu
Rosenthal
P
P
Brown
C C
CC
Busch
A M H
AM
Calcatera
S M
SM
Claria
R S
RS
Hunt
N K
NK
Korenblat
K M
KM
Mazariegos
G V
GV
Moonka
D
D
Orloff
S L
SL
Perry
D K
DK
Rosen
C B
CB
Scott
D L
DL
Sudan
D L
DL
D000328:Adult; D002648:Child; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000473:pathology / Q000628:therapy; D008107:Liver Diseases / Q000473:pathology / Q000628:therapy; D016031:Liver Transplantation / Q000379:methods*; D011182:Postoperative Care; D011320:Primary Health Care / Q000379:methods* / Q000592:standards*; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents